Evidence map›Paper›PMID 42728405›Full record

ReviewNature protocols2026

Generation of eight-cell embryo-like cells from human pluripotent stem cells.

Md Abdul Mazid, Yunpan Li, Mindie Zhao, Lixin Fu, Hao Liu, Yu Jiang, Wenqi Jia, Junjian Lai, Jinxiu Li, Haiwei Li and 12 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Md Abdul Mazid *Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. mazid@gibh.ac.cn.ORCID http://orcid.org/0000-0001-7909-4422
Yunpan Li *Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Mindie Zhao *Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Lixin FuUniversity of Chinese Academy of Sciences, Beijing, China.
Hao LiuGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Yu JiangGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Wenqi JiaGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Junjian LaiBGI Research, Shenzhen, China.
Jinxiu LiUniversity of Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0009-0008-8526-1942
Haiwei LiJoint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou Medical University, Guangzhou, China.
Babangida Jabir SaeedGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Amash ManzoorGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Zhiwei LuoGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Yiwei LaiBGI Research, Shenzhen, China.
Liang WuBGI Research, Shenzhen, China.ORCID http://orcid.org/0000-0002-6784-0181
Yi ZouBGI Research, Shenzhen, China.
Chaiyaboot AriyachetDepartment of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Carl WardGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.ORCID http://orcid.org/0000-0003-0889-9025
Chuanyu LiuBGI Research, Shenzhen, China.ORCID http://orcid.org/0000-0003-2258-0897
Longqi LiuBGI Research, Hangzhou, China.
Miguel A EstebanBGI Research, Shenzhen, China. miguelesteban@genomics.cn.ORCID http://orcid.org/0000-0002-1426-6809
Wenjuan LiGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. li_wenjuan@gibh.ac.cn.ORCID http://orcid.org/0000-0003-4252-1026

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammalian embryonic development is a highly orchestrated process initiated by the fusion of the oocyte with sperm to generate the zygote. In humans, the zygote remains transcriptionally quiescent until the major wave of zygotic genome activation (ZGA) occurs around the eight-cell (8C) stage (day 3 after fertilization). These cells and the derived morula cells are totipotent: they have the capacity to form a whole individual. Our understanding of human totipotency is very limited because of ethical concerns using embryos and the scarcity of material available for research. Recently, we established a controllable transgene-free methodology to generate totipotent eight-cell embryo-like cells (8CLCs) from human pluripotent stem cells (PSCs) in vitro. These 8CLCs are produced using a novel medium, formulated by us, containing specific chemical compounds and cytokines. Here, we provide a detailed protocol for inducing, isolating and characterizing 8CLCs generated with this medium. The induction process can be done either in a stepwise manner (primed-naive-8CLC) that requires only 5 d starting from naive PSCs or directly from primed PSCs, which takes ~7 d. The resulting 8CLCs exhibit transcriptional and epigenetic features resembling those of human 8C embryo cells. On the basis of our experience, we expect that an individual with ~1 year of experience working with human PSC culture would be able to carry out this protocol. Our approach provides a valuable model for studying human early embryogenesis, particularly the molecular events surrounding ZGA.

Identifiers

PMID42728405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.